Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: Adolescents who lost 5% or more from baseline vs. those who lost less than 5%

Contraception

Volumn 82, Issue 6, 2010, Pages 503-512

  Harel, Zeev ^a   Wolter, Kevin ^b   Gold, Melanie A ^c   Cromer, Barbara ^d   Stager, Margaret ^d   Johnson, Christine Cole ^e   Brown, Robert ^f   Bruner, Ann ^g   Coupey, Susan ^h   Hertweck, Paige ⁱ   Bone, Henry ^j   Burkman, Ronald ^k   Nelson, Anita ^l   Marshall, Sharon ^m   Bachrach, Laura K ⁿ  

^a BROWN UNIVERSITY   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ University of Louisville School of Medicine   (United States)

^j Michigan Bone and Mineral Clinic   (United States)

^k BAYSTATE MEDICAL CENTER   (United States)

^l HARBOR UCLA MEDICAL CENTER   (United States)

^m CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

ⁿ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Adolescents; Bone markers; Bone mineral density; Female; Medroxyprogesterone acetate (DMPA, Depo Provera )

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADOLESCENT; ALCOHOL CONSUMPTION; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CALCIUM INTAKE; CLINICAL TRIAL; CONTRACEPTION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; HIP; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; LUMBAR SPINE; MULTICENTER STUDY; NORMAL HUMAN; OSTEOLYSIS; PHYSICAL ACTIVITY; SIDE EFFECT; SOCIAL PSYCHOLOGY;

ADOLESCENT; ALCOHOL DRINKING; BONE DENSITY; CHILD; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; ESTRADIOL; FEMALE; HIP JOINT; HUMANS; LUMBAR VERTEBRAE; MEDROXYPROGESTERONE ACETATE; PROSPECTIVE STUDIES; SMOKING;

EID: 78249231368     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.04.022     Document Type: Article

References (39)

1. Harel Z., and Cromer B. The use of long-acting contraceptives in adolescents Pediatr Clin North Am 46 1999 719 732
2. Piccinino L.J., and Mosher W.D. Trends in contraceptive use in the United States: 1982-1995 Fam Plann Perspect 30 1998 4 10
3. US Bureau of the Census Use of contraception and use of family planning services in the United States: 1995-2002, table 95 www.census.gov/compendia/ statab/tables/09s0095.pdf Accessed November 28, 2009
4. Cundy T., Evans M., Roberts H., Wattie D., Ames R., and Reid I.R. Bone density in women receiving depot medroxyprogesterone acetate for contraception BMJ 303 1991 13 16
5. Gbolade B., Ellis S., Murby B., Randall S., and Kirkman R. Bone density in long-term users of depot medroxyprogesterone acetate Br J Obstet Gynaecol 105 1998 790 794
6. Cundy T., Cornish J., Roberts H., Elder H., and Reid I.R. Spinal bone density in women using depot medroxyprogesterone contraception Obstet Gynecol 92 1998 569 573
7. Paiva L.C., Pinto-Neto A.M., and Faundes A. Bone density amongst long-term users of medroxyprogesterone acetate as a contraceptive Contraception 58 1998 351 355
8. Scholes D., Lacroix A.Z., Ott S.M., Ichikawa L.E., and Barlow W.E. Bone mineral density in women using depot medroxyprogesterone for contraception Obstet Gynecol 93 1999 233 238
9. Tang O.S., Tang G., Yip P., Li B., and Fan S. Long-term depot medroxyprogesterone acetate and bone mineral density Contraception 59 1999 25 29
10. Cromer B.A., Blair J.M., Mahan J.D., Zibners L., and Naumovski Z. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives J Pediatr 129 1996 671 676
11. Busen N.H., Britt R.B., and Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxprogesterone acetate for one to two years J Adolesc Health 32 2003 257 259
12. Lara-Torre E., Edwards C.P., Perlman S., and Hertweck S.P. Bone mineral density in adolescent females using depot medroxyprogesterone acetate J Pediatr Adolesc Gynecol 17 2004 17 21
13. Cromer B.A., Stager M., and Bonny A. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls J Adolesc Health 35 2004 434 441 (Pubitemid 39576013)
14. Http:// www.fda.gov/medwatch/SAFETY/2004/DepoProvera-Label.pdf. Accessed January 27, 2005.
15. Cromer A.C., Scholes D., Berenson A., Cundy T., Clark M.K., and Kaunitz A.M. Depot medroxyprogesterone acetate and bone mineral density in adolescents - the black box warning: a position paper of the Society for Adolescent Medicine J Adolecs Health 39 2006 296 301
16. Ott S.M., Scholes D., LaCroix A.Z., Ichikawa L.E., Yoshida C.K., and Barlow W.E. Effects of contraceptive use on bone biochemical markers in young women J Clin Endocrinol Metab 86 2001 179 185
17. Rome E., Ziegler J., and Secic M. Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive J Pediatr Adolesc Gynecol 17 2004 373 377
18. Jeppsson S., Gershagen S., Johansson E.D.B., and Rannevik G. Serum medroxyprogesterone (MPA), sex hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA as a contraceptive Acta Endocrinol 99 1982 339 343
19. Clark M.K., Sowers M., Levy B.T., and Tenhundfeld P. Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception Fertil Steril 75 2001 871 877
20. Johnson C.C., Burkman R.T., and Gold M.A. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density Contraception 77 2008 239 248
21. Harel Z., Johnson C.C., and Gold M.A. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections Contraception 81 2010 281 291
22. Hanson J. Standardization of femur BMD J Bone Miner Res 12 1997 1316 1317
23. Hui S.L., Gao S., and Zhou X.H. Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments J Bone Miner Res 12 1997 1463 1470
24. Marcus R. New perspectives on the skeletal role of estrogen J Clin Endocrinol Metab 83 1998 2236 2238
25. Slemenda C., Longcope C., Peacock M., Hui S., and Johnston C.C. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women J Clin Invest 97 1996 14 21
26. Nordin B.E.C. Calcium and osteoporosis Nutrition 13 1997 664 686
27. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, and Institute of Medicine Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride 1997 National Academy Press Washington, DC
28. Wagner C.L., and Greer F.R. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents Pediatrics 122 2008 1142 1152
29. Merki-Feld G.S., Neff M., and Keller P.J. A 2-year prospective study on the effects of depot medroxyprogesterone acetate on bone mass-response to estrogen and calcium therapy in individual users Contraception 67 2003 79 86
30. French S.A., Fulkerson J.A., and Story M. Increasing weight-bearing physical activity and calcium intake for bone mass growth in children and adolescents: a review of intervention trials Prev Med 31 2000 722 731
31. Law M.R., and Hackshaw A.K. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect BMJ 315 1997 841 846
32. Elgan C., Samsioe G., and Dykes A.K. Influence of smoking and oral contraceptives on bone mineral density and bone remodeling in young women: a 2-year study Contraception 67 2003 439 447
33. Clark M.K., Sowers M.F., Dekordi F., and Nichols S. Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery Osteoporos Int 14 2003 396 403
34. Leonard M.B., Shults J., Wilson B.A., Tershakovec A.M., and Zemel B.S. Obesity during childhood and adolescence augments bone mass and bone dimensions Am J Clin Nutr 80 2004 514 523
35. Klein K.O., Larmore K.A., de Lancey E., Brown J.M., Considine R.V., and Hassink S.G. Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children J Clin Endocrinol Metab 83 1998 3469 3475
36. Harel Z., Biro F.M., and Kollar L.M. Depo-Provera in adolescents: Effects of early second injection or prior oral contraception J Adolesc Health 16 1995 379 384
37. Bonny A.E., Britto M.T., Huang B., Succop P., and Slap G.B. Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA) J Pediatr Adolesc Gynecol 17 2004 109 115
38. Heaney R.P. Measuring bone mass accumulation Am J Clin Nutr 79 2004 341
39. Scholes D., LaCroix A.Z., and Ichikawa L.E. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception Arch Pediatr Adolesc Med 159 2005 139 144